Hepatocyte growth factor (HGF) has mitogenic, motogenic, and morphogenic biological activities as well as helps in regenerating various tissues. In cardiovascular organs, HGF was reported to have anti-apoptotic, anti-fibrotic, and vasodilating effects. HGF has close relationships with hypertension, arteriosclerosis, and heart failure. HGF enhances renal regeneration and suppresses the progression of hypertension. Intramuscular electroporation of the therapeutic gene is a simple, economic, and low toxic method compared with systemic administration of the purified proteins or peptides. We outline the technique of intramuscular electroporation of HGF gene as a remedy for hypertension.
CITATION STYLE
Komamura, K., Miyazaki, J. I., Imai, E., Matsumoto, K., Nakamura, T., & Hori, M. (2008). Hepatocyte growth factor gene therapy for hypertension. Methods in Molecular Biology (Clifton, N.J.), 423, 393–404. https://doi.org/10.1007/978-1-59745-194-9_31
Mendeley helps you to discover research relevant for your work.